Survival analysis in second-line and third-line chemotherapy with irinotecan followed by topotecan or topotecan followed by irinotecan for extensive-stage small-cell lung cancer patients: a single-center retrospective study

Survival analysis in second-line and third-line chemotherapy with irinotecan followed by topotecan or topotecan followed by irinotecan for extensive-stage small-cell lung cancer patients: a single-center retrospective study

Gokmen Aktas,1 Tulay Kus,1 Mehmet Emin Kalender,1 Alper Sevinc,1 Celaletdin Camci,1 Seval Kul2 1Division of Medical Oncology, Department of Internal Medicine, School of Medicine, Gaziantep Oncology Hospital, Gaziantep University, Gaziantep, Turkey; 2Department of Biostatistics, School of Medicine,...

Full description

Bibliographic Details
Main Authors: Aktas G, Kus T, Kalender ME, Sevinc A, Camci C, Kul S
Format: Article
Language:English
Published: Dove Medical Press 2016-04-01
Series:OncoTargets and Therapy
Subjects:
Small-cell lung cancer
irinorecan
topotecan
third-line chemotherapy
Online Access:https://www.dovepress.com/survival-analysis-in-second-line-and-third-line-chemotherapy-with-irin-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/survival-analysis-in-second-line-and-third-line-chemotherapy-with-irin-peer-reviewed-article-OTT

Similar Items